Foot Manipulation for Pregnancy Related Pelvic Girdle Pain
Launched by VASTRA GOTALAND REGION · Jul 2, 2013
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
The study was performed at the physiotherapy clinics at five Health Care Centres in Skaraborg from September 2009 to August 2011. Women with suspected PPGP were referred by midwifes or physicians or contacted the physiotherapists directly. Inclusion criteria were Swedish-speaking women in gestational weeks 12-31 with PPGP determined by specific provocation tests, including the 4P test (posterior pelvic pain provocation test), Patrick's test, ASLR (active straight leg raise test), modified Trendelenburg test and palpation of symphysis pubis. Women with twin pregnancies, lumbar pain, rheumati...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with suspected PPGP were referred by midwifes or physicians or contacted the physiotherapists directly.
- Inclusion criteria:
- • Swedish-speaking women in gestational weeks 12-31
- • Pregnancy Related Pelvic Girdle Pain (PPGP) determined by provocation tests (4P test, posterior pelvic pain provocation test; Patrick's test, ASLR (active straight leg raise test), modified Trendelenburg test and pain on palpation of symphysis pubis
- Exclusion Criteria:
- Women with:
- • twin pregnancies
- • lumbar pain
- • rheumatic or other serious disease
- • non-Swedish-speaking woman
- • those who had had experinced foot manipulation earlier
About Vastra Gotaland Region
Vastra Gotaland Region is a prominent healthcare organization in Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a sponsor, the region leverages its extensive network of hospitals and healthcare professionals to facilitate high-quality research initiatives that address pressing health challenges. With a commitment to ethical standards and patient safety, Vastra Gotaland Region strives to foster collaboration between researchers, clinicians, and patients, ensuring that clinical trials contribute valuable insights and advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tibro, , Sweden
Patients applied
Trial Officials
Camilla Melkersson, Physiother
Principal Investigator
R&D Centre, Skaraborg Primary Care, Skövde, Sweden
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials